Critical Path Institute Launches Type 1 Diabetes Consortium March 20, 2017 Critical Path Institute Launches Type 1 Diabetes Consortium Tucson, Ariz., March 20, 2017 –Critical Path Institut
March 2, 2017 Safety, Dosing, and Pharmaceutical Quality for Studies That Evaluate Medicinal Products (Including Biological Products) in Neonates Ward RM, Benjamin D, Barrett JS, Allegaert K, Portman R, Davis JM, Turner MA, and the International Neonatal Consortium. Safety, D
January 3, 2017 Removing the Bottleneck in Whole Genome Sequencing of Mycobacterium Tuberculosis for Rapid Drug Resistance Analysis: A Call to Action
February 28, 2017 Considerations for Requiring Subjects to Respond to PRO Instruments Collected Electronically This webinar provides an overview of specific considerations related to allowing subjects to opt out of responding to individual i
Biomarker Qualification: Collaboration, Strategy, and Implementation Biomarker Qualification: Collaboration, Strategy, and Implementation Webinar February 24th, 2017 Presenter: John Michael Sauer, Ph
February 1, 2017 Validity of Low-Contrast Letter Acuity as a Visual Performance Outcome Measure for Multiple Sclerosis
February 1, 2017 The Nine-Hole Peg Test as a Manual Dexterity Performance Measure for Multiple Sclerosis